Cite
MLA Citation
Michael Wang et al.. “Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.” Lancet, vol. 391, no. 10121, 2018, pp. 659–667. http://access.bl.uk/ark:/81055/vdc_100057098379.0x000054